Global Screening OncoGenesis offers an end-to-end screening platform combining the iPap self-collection device with the CerMark biomarker test, designed for easy deployment in clinics, labs, and homes, including resource-limited regions. Sales opportunities include partnerships with public health programs, clinics, laboratories, NGOs, and national screening initiatives to implement population-wide cervical cancer screening, emphasizing privacy and accessibility to drive adoption.

Lab to POC CerMark is planned to roll out from a laboratory-based system to a point-of-care device, creating a two-track sales motion: initial lab partnerships for validation and reimbursement, followed by expansion into POC settings in clinics and mobile health units. Opportunities include targeting reference labs and hospital systems for early pilots, then leveraging POC devices for remote or underserved markets with bundled offerings.

Strategic Partnerships Past collaboration with Quanterix demonstrates potential for biomarker collaboration and co-development; pursue licensing, co-marketing, and integrator partnerships with diagnostic platforms to accelerate sales cycles and credibility. Opportunities include engaging with biomarker and diagnostics partners, contract research organizations, and global health collaborators to scale adoption.

Leadership Momentum New CEO Teresa Prego was appointed in October 2023, signaling a growth-oriented leadership and a clear narrative for enterprise sales and fundraising. Opportunities include leveraging the leadership transition to engage strategic partners and investors, align go-to-market plans with regulatory milestones, and accelerate government or institutional procurement discussions.

Lean Channel With a small team and a cost-effective, globally deployable solution, OncoGenesis can accelerate growth through channel partnerships and service-enabled deployments. Sales opportunities include building a partner ecosystem of distributors and lab networks, offering co-branded pilots, and pursuing grant-funded initiatives to scale adoption.